Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
37.23
+0.29 (0.79%)
Nov 21, 2024, 12:41 PM EST - Market open
Moderna Analyst Ratings
Total Analysts
17
Consensus Rating
Hold
Price Target
$83.00
Upside
+122.94%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Reiterates $115 → $69 | Buy | Reiterates | $115 → $69 | +85.33% | Nov 18, 2024 |
HSBC | HSBC | Hold → Strong Buy Upgrades $58 | Hold → Strong Buy | Upgrades | $58 | +55.79% | Nov 18, 2024 |
Wolfe Research | Wolfe Research | Sell Initiates $40 | Sell | Initiates | $40 | +7.44% | Nov 15, 2024 |
Barclays | Barclays | Buy Maintains $125 → $111 | Buy | Maintains | $125 → $111 | +198.15% | Nov 8, 2024 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 8, 2024 |
JP Morgan | JP Morgan | Sell Maintains $70 → $59 | Sell | Maintains | $70 → $59 | +58.47% | Nov 4, 2024 |
UBS | UBS | Strong Buy Maintains $140 → $108 | Strong Buy | Maintains | $140 → $108 | +190.09% | Oct 24, 2024 |
Bernstein | Bernstein | Hold Initiates $55 | Hold | Initiates | $55 | +47.73% | Oct 17, 2024 |
Jefferies | Jefferies | Hold Maintains $65 → $55 | Hold | Maintains | $65 → $55 | +47.73% | Oct 15, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $75 | Hold | Reiterates | $75 | +101.45% | Sep 19, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $178 → $139 | Strong Buy | Maintains | $178 → $139 | +273.35% | Sep 16, 2024 |
Barclays | Barclays | Buy Maintains $155 → $125 | Buy | Maintains | $155 → $125 | +235.75% | Sep 16, 2024 |
B of A Securities | B of A Securities | Hold Maintains $130 → $110 | Hold | Maintains | $130 → $110 | +195.46% | Sep 13, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $157 → $115 | Buy | Maintains | $157 → $115 | +208.89% | Sep 13, 2024 |
TD Cowen | TD Cowen | Hold Maintains $70 → $60 | Hold | Maintains | $70 → $60 | +61.16% | Sep 13, 2024 |
RBC Capital | RBC Capital | Hold Maintains $90 → $75 | Hold | Maintains | $90 → $75 | +101.45% | Sep 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.